"Visit our website for the latest information about COVID-19 for patients and visitors, UCSF offers video visits for many health care needs. Contact your provider's office to make a telehealth appointment. Visit our website to learn about the safety precautions we have in place during COVID-19 to protect your health at our hospitals and clinics."

During the past decade, Weill Institute for Neurosciences, University of California, San Francisco conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Weill Institute for Neurosciences, University of California, San Francisco" are "Multiple Sclerosis" (2 trials), "Cognitive Decline" (1 trials) and "Multiple Sclerosis, Relapsing-Remitting" (1 trials). Many other conditions were trialed in "Weill Institute for Neurosciences, University of California, San Francisco" in a lesser frequency.

Most popular intervention types in "Weill Institute for Neurosciences, University of California, San Francisco" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bazedoxifene Acetate" (1 trials), "Computerized gaming rehabilitation Program 1" (1 trials) and "Computerized gaming rehabilitation Program 2" (1 trials). Other intervention names were less common.

The vast majority of trials in "Weill Institute for Neurosciences, University of California, San Francisco" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Weill Institute for Neurosciences, University of California, San Francisco". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Weill Institute for Neurosciences, University of California, San Francisco, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Weill Institute for Neurosciences, University of California, San Francisco, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".